Enara Bio
-
Enara Bio enters strategic collaboration with Boehringer Ingelheim
The strategic collaboration and licensing agreement will research and develop novel targeted cancer immunotherapies, leveraging Enara Bio’s Dark Antigen™ discovery platform.
-
Enara Bio relocates to the Bellhouse Building at The Oxford Science Park
The move from the Oxford BioEscalator to one of the UK’s largest biomedical innovation centres is in preparation for its future growth and ambition to transform cancer care.